Movement Alert|Boston Scientific Intraday Decline 4.94%, Cybersecurity Incident Triggers Global Operational Disruptions

Market Focus
Yesterday

On August 26, Boston Scientific fell 4.94% in regular trading, trading at $47.78/share, with turnover of $183 million. The decline was driven by the company's disclosure of a cybersecurity incident that has caused widespread disruption to its global operations.

According to a filing with the SEC, Boston Scientific identified a cybersecurity incident affecting certain IT systems, leading to global operational disruption. The company stated the incident continues to impact operations, limiting the processing and shipment of customer orders. The timeline for full restoration remains unknown, and the company has not yet determined whether the incident will have a material impact on its financial results.

The stock was already under pressure following a Q2 earnings report in late July that saw the company lower full-year adjusted EPS guidance to $3.28-$3.32, below the consensus estimate of $3.36. The Watchman business is expected to see mid-to-high single-digit revenue declines in the second half, and multiple analysts subsequently cut price targets, with Argus downgrading the stock to Hold.

(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10